Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Sep-23 4:30 PM View:  | McClellan William D. Jr. Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 6,017 | -- | -- | (100%) 6.02K to 0 | |
| 26-Sep-23 4:30 PM View: | Ruff Shamim Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 7,359 | -- | -- | (100%) 7.36K to 0 | |
| 26-Sep-23 4:30 PM View: | Rose William Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 379,281 | -- | -- | (63%) 599.58K to 220.3K | |
| 26-Sep-23 4:30 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 62,621 | -- | -- | (100%) 62.62K to 0 | |
| 26-Sep-23 4:30 PM View: | Loewen Andrea SVP, Global Regulatory Affairs | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 28,416 | -- | -- | (100%) 28.42K to 0 | |
| 26-Sep-23 4:30 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 24,089 | -- | -- | (100%) 24.09K to 0 | |
| 26-Sep-23 7:18 PM View: | McGaughy R Kent Jr Director 10% Owner | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 25,004 | -- | -- | (< 1%) 2.93M to 2.9M | |
| 26-Sep-23 4:30 PM View: | Meyer Colin John Chief Innovation Officer | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 81,633 | -- | -- | (100%) 81.63K to 0 | |
| 26-Sep-23 4:30 PM View: | Rose William Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 31,413 | -- | -- | (14%) 220.3K to 188.89K | |
| 28-Sep-23 4:32 PM View: | Desai Antal Rohit Director 10% Owner | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 2,928,370 | -- | -- | (100%) 2.93M to 0 | |
| 26-Sep-23 4:30 PM View: | Wortley Michael D Chief Legal Officer | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 49,701 | -- | -- | (100%) 49.7K to 0 | |
| 26-Sep-23 4:30 PM View: | Huff James Warren Chief Executive Officer Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 122,480 | -- | -- | (92%) 132.88K to 10.4K | |
| 26-Sep-23 4:30 PM View: | Ryder Steven Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 10,907 | -- | -- | (100%) 10.91K to 0 | |
| 26-Sep-23 7:18 PM View: | McGaughy R Kent Jr Director 10% Owner | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 2,901,770 | -- | -- | (100%) 2.9M to 0 | |
| 26-Sep-23 4:30 PM View: | Oliger Christy J. Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 5,565 | -- | -- | (100%) 5.57K to 0 | |
| 26-Sep-23 4:30 PM View: | Patni Rajiv EVP, Chief R&D Officer | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 45,000 | -- | -- | (100%) 45.0K to 0 | |
| 26-Sep-23 4:30 PM View: | Rose William Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 188,889 | -- | -- | (100%) 188.89K to 0 | |
| 26-Sep-23 4:30 PM View: | Edwards Martin Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 6,116 | -- | -- | (100%) 6.12K to 0 | |
| 26-Sep-23 4:30 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 33,805 | -- | -- | (100%) 33.8K to 0 | |
| 26-Sep-23 4:30 PM View: | Huff James Warren Chief Executive Officer Director | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 10,398 | -- | -- | (100%) 10.4K to 0 | |
| 18-Sep-23 5:34 PM View: | Loewen Andrea SVP, Global Regulatory Affairs | Reata Pharmaceuticals Inc (RETA) | 14-Sep-23 | Private Sale | 3,175 | $172.02 | $546,181.00 | (10%) 31.59K to 28.42K | |
| 07-Sep-23 4:11 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 05-Sep-23 | Private Sale | 406 | $169.20 | $68,695.20 | (2%) 24.5K to 24.09K | |
| 24-Aug-23 4:41 PM View: | Rose William Director | Reata Pharmaceuticals Inc (RETA) | 23-Aug-23 | Gift | 500,000 | -- | -- | (45%) 1.1M to 599.58K | |
| 17-Aug-23 4:43 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Private Sale | 1,755 | $168.41 | $295,566.00 | (3%) 64.38K to 62.62K | |
| 17-Aug-23 4:35 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Sale | 398 | $168.33 | $66,996.00 | (1%) 34.2K to 33.8K | |
| 17-Aug-23 4:31 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Sale | 210 | $168.42 | $35,367.90 | (< 1%) 24.7K to 24.5K | |
| 17-Aug-23 4:40 PM View: | Meyer Colin John Chief Innovation Officer | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Sale | 596 | $168.74 | $100,569.00 | (< 1%) 82.23K to 81.63K | |
| 17-Aug-23 4:46 PM View: | Wortley Michael D Chief Legal Officer | Reata Pharmaceuticals Inc (RETA) | 16-Aug-23 | Sale | 398 | $168.76 | $67,166.70 | (< 1%) 50.1K to 49.7K | |
| 17-Aug-23 4:35 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 15-Aug-23 | Private Sale | 807 | $169.04 | $136,413.00 | (2%) 35.01K to 34.2K | |
| 17-Aug-23 4:31 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 15-Aug-23 | Private Sale | 193 | $169.05 | $32,627.60 | (< 1%) 24.9K to 24.7K | |
| 17-Aug-23 4:40 PM View: | Meyer Colin John Chief Innovation Officer | Reata Pharmaceuticals Inc (RETA) | 15-Aug-23 | Private Sale | 2,144 | $169.07 | $362,483.00 | (3%) 84.37K to 82.23K | |
| 17-Aug-23 4:46 PM View: | Wortley Michael D Chief Legal Officer | Reata Pharmaceuticals Inc (RETA) | 15-Aug-23 | Private Sale | 807 | $169.04 | $136,415.00 | (2%) 50.91K to 50.1K | |
| 01-Aug-23 4:35 PM View: | McClellan William D. Jr. Director | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Sale (Planned) | 5,000 | $164.49 | $822,442.00 | (45%) 11.02K to 6.02K | |
| 01-Aug-23 4:41 PM View: | Ruff Shamim Director | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Option Exercise | 8,235 | $92.20 | $759,267.00 | 112% 7.36K to 15.59K | |
| 01-Aug-23 4:29 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Conversion | 40,000 | -- | -- | 114% 35.01K to 75.01K | |
| 01-Aug-23 4:47 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Sale (Planned) | 75,000 | $164.62 | $12,346,300.00 | (54%) 139.38K to 64.38K | |
| 01-Aug-23 4:35 PM View: | McClellan William D. Jr. Director | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Conversion | 5,000 | -- | -- | 83% 6.02K to 11.02K | |
| 01-Aug-23 4:41 PM View: | Ruff Shamim Director | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Planned Option Sale | 8,235 | $164.53 | $1,354,890.00 | (53%) 15.59K to 7.36K | |
| 01-Aug-23 4:47 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Conversion | 75,000 | -- | -- | 117% 64.38K to 139.38K | |
| 01-Aug-23 4:29 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 28-Jul-23 | Sale (Planned) | 40,000 | $164.54 | $6,581,430.00 | (53%) 75.01K to 35.01K | |
| 10-Jul-23 4:45 PM View: | Meyer Colin John Chief Innovation Officer | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 6,000 | -- | -- | 8% 78.37K to 84.37K | |
| 10-Jul-23 4:49 PM View: | Wortley Michael D Chief Legal Officer | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 4,125 | -- | -- | 9% 46.78K to 50.91K | |
| 10-Jul-23 4:42 PM View: | Bir Dawn Carter Chief Commercial Officer | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 4,125 | -- | -- | 13% 30.89K to 35.01K | |
| 10-Jul-23 4:38 PM View: | Huff James Warren Chief Executive Officer Director | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 84,220 | -- | -- | 173% 48.66K to 132.88K | |
| 10-Jul-23 4:47 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 06-Jul-23 | Grant | 6,000 | -- | -- | 10% 58.38K to 64.38K | |
| 16-Jun-23 4:03 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 14-Jun-23 | Sale | 781 | $102.11 | $79,749.30 | (3%) 25.68K to 24.9K | |
| 16-Jun-23 4:03 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 14-Jun-23 | Option Exercise | 1,562 | $27.32 | $42,673.80 | 6% 25.68K to 27.24K | 4% |
| 16-Jun-23 4:03 PM View: | Anand Bhaskar SVP, Chief Accounting Officer | Reata Pharmaceuticals Inc (RETA) | 14-Jun-23 | Private Option Sale | 1,562 | $102.11 | $159,499.00 | (6%) 27.24K to 25.68K | |
| 14-Jun-23 4:35 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 13-Jun-23 | Sale | 57,796 | $102.89 | $5,946,760.00 | (50%) 116.17K to 58.38K | |
| 14-Jun-23 4:35 PM View: | Soni Manmeet Singh COO, CFO and President | Reata Pharmaceuticals Inc (RETA) | 13-Jun-23 | Option Exercise | 25,000 | $27.32 | $683,000.00 | 22% 111.46K to 136.46K |
